707 related articles for article (PubMed ID: 21653215)
1. Bevacizumab for Coats' disease with exudative retinal detachment and risk of vitreoretinal traction.
Ramasubramanian A; Shields CL
Br J Ophthalmol; 2012 Mar; 96(3):356-9. PubMed ID: 21653215
[TBL] [Abstract][Full Text] [Related]
2. Combination treatment of pediatric coats' disease: a bicenter study in Taiwan.
Lin CJ; Chen SN; Hwang JF; Yang CM
J Pediatr Ophthalmol Strabismus; 2013; 50(6):356-62. PubMed ID: 24669373
[TBL] [Abstract][Full Text] [Related]
3. Risk of Tractional Retinal Detachment Following Intravitreal Bevacizumab Along with Subretinal Fluid Drainage and Cryotherapy for Stage 3B Coats' Disease.
Bhat V; D'Souza P; Shah PK; Narendran V
Middle East Afr J Ophthalmol; 2016; 23(2):208-11. PubMed ID: 27162454
[TBL] [Abstract][Full Text] [Related]
4. The effect of intravitreal bevacizumab injection as the initial treatment for Coats' disease.
Zheng XX; Jiang YR
Graefes Arch Clin Exp Ophthalmol; 2014 Jan; 252(1):35-42. PubMed ID: 23873253
[TBL] [Abstract][Full Text] [Related]
5. A combination of intravitreal bevacizumab injection with tunable argon yellow laser photocoagulation as a treatment for adult-onset Coats' disease.
Wang KY; Cheng CK
J Ocul Pharmacol Ther; 2011 Oct; 27(5):525-30. PubMed ID: 21951171
[TBL] [Abstract][Full Text] [Related]
6. Successful use of intravitreal bevacizumab and pascal laser photocoagulation in the management of adult Coats' disease.
Raoof N; Quhill F
Middle East Afr J Ophthalmol; 2013; 20(3):256-8. PubMed ID: 24014992
[TBL] [Abstract][Full Text] [Related]
7. Treatment of Coats' disease with intravitreal bevacizumab.
Ray R; Barañano DE; Hubbard GB
Br J Ophthalmol; 2013 Mar; 97(3):272-7. PubMed ID: 23269680
[TBL] [Abstract][Full Text] [Related]
8. Successful use of intravitreal ranibizumab injection and combined treatment in the management of Coats' disease.
Yang Q; Wei W; Shi X; Yang L
Acta Ophthalmol; 2016 Jun; 94(4):401-6. PubMed ID: 27150442
[TBL] [Abstract][Full Text] [Related]
9. Combined treatment for Coats' disease: retinal laser photocoagulation combined with intravitreal bevacizumab injection was effective in two cases.
Kodama A; Sugioka K; Kusaka S; Matsumoto C; Shimomura Y
BMC Ophthalmol; 2014 Mar; 14():36. PubMed ID: 24666524
[TBL] [Abstract][Full Text] [Related]
10. TRANSCLERAL DRAINAGE OF SUBRETINAL FLUID, ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR, AND WIDE-FIELD IMAGING-GUIDED LASER IN COATS EXUDATIVE RETINAL DETACHMENT.
Stanga PE; Jaberansari H; Bindra MS; Gil-Martinez M; Biswas S
Retina; 2016 Jan; 36(1):156-62. PubMed ID: 26355946
[TBL] [Abstract][Full Text] [Related]
11. Resolution of total retinal detachment in Coats' disease with intravitreal injection of bevacizumab.
Zhao T; Wang K; Ma Y; Jiang YR
Graefes Arch Clin Exp Ophthalmol; 2011 Nov; 249(11):1745-6. PubMed ID: 21080196
[No Abstract] [Full Text] [Related]
12. EXTRAMACULAR FIBROSIS IN COATS' DISEASE.
Daruich A; Matet A; Tran HV; Gaillard MC; Munier FL
Retina; 2016 Oct; 36(10):2022-8. PubMed ID: 26991649
[TBL] [Abstract][Full Text] [Related]
13. ranibizumab in the management of advanced Coats disease Stages 3B and 4: long-term outcomes.
Gaillard MC; Mataftsi A; Balmer A; Houghton S; Munier FL
Retina; 2014 Nov; 34(11):2275-81. PubMed ID: 25075562
[TBL] [Abstract][Full Text] [Related]
14. Elevated vascular endothelial growth factor level in Coats' disease and possible therapeutic role of bevacizumab.
He YG; Wang H; Zhao B; Lee J; Bahl D; McCluskey J
Graefes Arch Clin Exp Ophthalmol; 2010 Oct; 248(10):1519-21. PubMed ID: 20379736
[TBL] [Abstract][Full Text] [Related]
15. The effects of a treatment combination of anti-VEGF injections, laser coagulation and cryotherapy on patients with type 3 Coat's disease.
Li S; Deng G; Liu J; Ma Y; Lu H
BMC Ophthalmol; 2017 May; 17(1):76. PubMed ID: 28532448
[TBL] [Abstract][Full Text] [Related]
16. [Adjuvant anti-VEGF therapy in Coats' disease].
Fiorentzis M; Stavridis E; Seitz B; Viestenz A
Ophthalmologe; 2015 May; 112(5):451-4. PubMed ID: 25134462
[TBL] [Abstract][Full Text] [Related]
17. Visual outcomes after treatment in pediatric patients with Coats' disease.
Chiu HH; Wan MJ; Kertes PJ; Muni RH; Lam WC
Can J Ophthalmol; 2019 Dec; 54(6):647-652. PubMed ID: 31836093
[TBL] [Abstract][Full Text] [Related]
18. Coats' disease: treatment with intravitreal bevacizumab and laser photocoagulation.
Stergiou PK; Symeonidis C; Dimitrakos SA
Acta Ophthalmol; 2009 Sep; 87(6):687-8. PubMed ID: 18976310
[No Abstract] [Full Text] [Related]
19. Coats disease in 351 eyes: Analysis of features and outcomes over 45 years (by decade) at a single center.
Shields CL; Udyaver S; Dalvin LA; Lim LS; Atalay HT; L Khoo CT; Mazloumi M; Shields JA
Indian J Ophthalmol; 2019 Jun; 67(6):772-783. PubMed ID: 31124485
[TBL] [Abstract][Full Text] [Related]
20. Integrating Scleral Buckling, Transscleral Drainage of Subretinal Fluid, Intravitreal Anti-Vascular Endothelial Growth Factor, and Laser Photocoagulation in Stage 3B Coats' Total Retinal Detachment.
Huang YC; Lai CC; Wu WC
Ophthalmic Surg Lasers Imaging Retina; 2016 Sep; 47(9):865-8. PubMed ID: 27631484
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]